Psilocybin and MDMA for Post-traumatic Stress Disorder (PTSD)
The purpose of this study is to assess the safety and effectiveness of co-administered MDMA and psilocybin in military Veterans with a diagnosis of Posttraumatic Stress Disorder (PTSD). To apply or learn more, please view our website: https://hopkinspsychedelic.org/pamvet
- Status
- recruiting
- Phase
- Phase 1
- Institution
- Johns Hopkins University
- Principal investigator
- Brandon Weiss, PhD
- Start date
- 2025-09-17
- End date
- 2029-08-01
- Registry ID
- NCT06989957
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.